• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肾细胞癌中的端粒酶活性

Telomerase activity in human renal cell carcinoma.

作者信息

Mehle C, Piatyszek M A, Ljungberg B, Shay J W, Roos G

机构信息

Department of Pathology, Umea University, Sweden.

出版信息

Oncogene. 1996 Jul 4;13(1):161-6.

PMID:8700542
Abstract

Telomeres have a vital role in maintaining chromosome stability and are essential for long term viability. Since the very ends of linear chromosomes cannot replicate, telomeres shorten in normal somatic cells eventually resulting in growth inhibition. However, most immortal cell lines maintain stable telomeres indicating that mechanisms exist to compensate for the end replication problem. Telomerase activity, leading to synthesis of telomeric DNA repeats, has been proposed to be an important step in the immortalization process of tumor cells. In the present study, 56 renal cell carcinomas were tested for telomerase activity using the sensitive TRAP (telomeric repeat amplification protocol). Forty of the analysed tumors (71%) were positive for telomerase activity, whereas none of the 56 corresponding normal kidney samples showed telomerase activity. All telomerase negative tumors had a reduction in mean telomere restriction fragment (TRF) length and a decrease in total telomere repeat hybridization signal, though cases were observed with an increase in peak TRF lengths. No obvious association between the presence of telomerase activity and clinicopathological parameters (histopathologic grade, DNA-ploidy, stage and clinical outcome) was found. The high frequency of detection of telomerase activity in the renal cell carcinomas indicates that this enzyme is likely to be an important factor involved in the evolution of this tumor type.

摘要

端粒在维持染色体稳定性方面起着至关重要的作用,对长期生存能力至关重要。由于线性染色体的末端无法复制,端粒在正常体细胞中会缩短,最终导致生长抑制。然而,大多数永生细胞系维持稳定的端粒,这表明存在补偿末端复制问题的机制。端粒酶活性可导致端粒DNA重复序列的合成,被认为是肿瘤细胞永生化过程中的一个重要步骤。在本研究中,使用灵敏的端粒重复序列扩增法(TRAP)检测了56例肾细胞癌的端粒酶活性。在所分析的肿瘤中,40例(71%)端粒酶活性呈阳性,而56例相应的正常肾组织样本均未显示端粒酶活性。所有端粒酶阴性的肿瘤平均端粒限制片段(TRF)长度均缩短,端粒重复序列杂交信号总量减少,不过也观察到有峰值TRF长度增加的病例。未发现端粒酶活性的存在与临床病理参数(组织病理学分级、DNA倍体、分期和临床结果)之间存在明显关联。肾细胞癌中端粒酶活性的高检出频率表明,该酶可能是参与这种肿瘤类型演变的一个重要因素。

相似文献

1
Telomerase activity in human renal cell carcinoma.人肾细胞癌中的端粒酶活性
Oncogene. 1996 Jul 4;13(1):161-6.
2
Telomere shortening in renal cell carcinoma.肾细胞癌中的端粒缩短
Cancer Res. 1994 Jan 1;54(1):236-41.
3
Telomere length dynamics in telomerase-positive immortal human cell populations.端粒酶阳性永生化人类细胞群体中的端粒长度动态变化
Exp Cell Res. 1998 Mar 15;239(2):370-8. doi: 10.1006/excr.1997.3907.
4
Analysis of telomerase activity and telomere function in cancer.癌症中端粒酶活性与端粒功能的分析
Methods Mol Biol. 2004;281:333-48. doi: 10.1385/1-59259-811-0:333.
5
Genetic changes and telomerase activity in human renal cell carcinoma.人类肾细胞癌中的基因变化与端粒酶活性
Clin Cancer Res. 1998 Jan;4(1):197-202.
6
Telomerase activity and alterations in telomere length in human brain tumors.人脑肿瘤中的端粒酶活性及端粒长度改变
Cancer Res. 1998 May 15;58(10):2117-25.
7
hTERT expression in sporadic renal cell carcinomas.散发性肾细胞癌中的人端粒酶逆转录酶(hTERT)表达
J Pathol. 2001 Sep;195(2):209-17. doi: 10.1002/path.917.
8
Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.人成纤维细胞永生化过程中的端粒动力学、端对端融合及端粒酶激活
Oncogene. 1999 Jul 22;18(29):4211-23. doi: 10.1038/sj.onc.1202797.
9
Multiple pathways to cellular senescence: role of telomerase repressors.细胞衰老的多种途径:端粒酶抑制因子的作用
Eur J Cancer. 1997 Apr;33(5):710-5. doi: 10.1016/S0959-8049(97)00090-7.
10
Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.结直肠癌中端粒长度、端粒酶活性及端粒重复序列结合因子1表达的相关性
Cancer. 2006 Feb 1;106(3):541-51. doi: 10.1002/cncr.21625.

引用本文的文献

1
Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma.较短的白细胞端粒长度与膀胱癌和肾细胞癌患者较差的生存率相关。
Cancers (Basel). 2021 Jul 27;13(15):3774. doi: 10.3390/cancers13153774.
2
Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.人端粒酶逆转录酶启动子控制和单纯疱疹病毒胸苷激酶武装的腺病毒治疗肾细胞癌。
Onco Targets Ther. 2013 Apr 18;6:419-26. doi: 10.2147/OTT.S41978. Print 2013.
3
A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT.
一种区分端粒酶和ALT永生化的基因表达特征揭示了一个hTERT调控网络,并提示ALT起源于间充质干细胞。
Oncogene. 2009 Oct 29;28(43):3765-74. doi: 10.1038/onc.2009.238. Epub 2009 Aug 17.
4
Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma cells.氟尿嘧啶诱导肝癌细胞凋亡过程中mTOR与端粒酶活性的协同下调
BMC Cancer. 2007 Nov 12;7:208. doi: 10.1186/1471-2407-7-208.
5
Telomerase activity in colorectal cancer, prognostic factor and implications in the microsatellite instability pathway.结直肠癌中的端粒酶活性、预后因素及其在微卫星不稳定性途径中的意义
World J Gastroenterol. 2007 Jul 28;13(28):3868-72. doi: 10.3748/wjg.v13.i28.3868.
6
The telomerase cycle: normal and pathological aspects.端粒酶循环:正常与病理方面
J Mol Med (Berl). 2005 Apr;83(4):244-57. doi: 10.1007/s00109-004-0616-2. Epub 2005 Jan 4.
7
Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.踮脚迈向染色体末端:当今人类端粒生物学的事实、前景与风险
Philos Trans R Soc Lond B Biol Sci. 2002 Apr 29;357(1420):545-62. doi: 10.1098/rstb.2001.1053.
8
High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma.端粒酶活性高与肾细胞癌基因组稳定性和DNA倍体相关。
Neoplasia. 2002 Mar-Apr;4(2):103-11. doi: 10.1038/sj.neo.7900205.
9
Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma.端粒酶活性在鼻咽癌诊断中的应用价值
Jpn J Cancer Res. 2000 Jul;91(7):760-6. doi: 10.1111/j.1349-7006.2000.tb01010.x.
10
Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse.恶性淋巴瘤诊断及复发时的端粒长度与端粒酶活性
Br J Cancer. 2000 Feb;82(3):601-7. doi: 10.1054/bjoc.1999.0970.